ARCHIVES

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

NSABP Roundup: Fisher, Pitt Negotiating; 9th Chairman Candidate

October 7, 1994

NCI Funding Plan For 1983: 20% Cut From Recommended Levels for All Grants, Change In Program Projects

October 8, 1982

Skin Cancer Screens Find “Extraordinary High” Rates

September 20, 1985

In Brief: Karmanos Institute Names Four To Faculty; $1.5M Donated To Kaplan Cancer Center

September 11, 1998

NCI Grant To Help Pitt Include Teaching End-of-Life Issues.

July 6, 2001

NCI Branch Chiefs, ACCI Join Support For DeVita

June 25, 1981